"Innovative Medical Research has been conducting clinical trials since 1996 and was incorporated in 1999. IMR has treated hundreds of patients and completed over 200 trials, participating in Phases I, II, III, and IV clinical trials. IMR is a fully-staffed clinical trial site consisting of study coordinators, a full-time Regulatory Director, a Principle Investigator and Sub-Investigators. IMR began as an Oncology/Hematology clinical trial center. IMR’s success in the treatment and administration of these studies lead them to expand further, not only in the number of conditions for which they conducted trials, but also to become a Multi-Specialty clinical trials center and Medical Device trial center."

During the past decade, Innovative Medical Research of South Florida, Inc. conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 13 clinical trials were completed, i.e. on average, 92.9% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Innovative Medical Research of South Florida, Inc." #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Abbott" with 2 trials sponsored, "Galena Biopharma, Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Agennix" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Innovative Medical Research of South Florida, Inc." #1 collaborator was "Bayer" with 1 trials as a collaborator, "Eisai Limited" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Innovative Medical Research of South Florida, Inc." are "Breast Cancer" (3 trials), "Cachexia" (2 trials), "Crohn Disease" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials) and "Opioid-use Disorder" (2 trials). Many other conditions were trialed in "Innovative Medical Research of South Florida, Inc." in a lesser frequency.

Most popular intervention types in "Innovative Medical Research of South Florida, Inc." are "Drug" (33 trials), "Other" (3 trials), "Biological" (2 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Etrolizumab" (3 trials), "Atrasentan" (2 trials), "Prednisone" (2 trials) and "0.9% Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Innovative Medical Research of South Florida, Inc." are 29 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Innovative Medical Research of South Florida, Inc.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Innovative Medical Research of South Florida, Inc., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Innovative Medical Research of South Florida, Inc., 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".